Stockreport

Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value [Seeking Alpha]

Aura Biosciences, Inc.  (AURA) 
PDF Play 18min Summary The positive end of phase 2 study data was achieved using bel-sar for the treatment of patients with intermediate lesions and small choroidal m [Read more]